Xeris Biopharma Holdings Inc notes that its commercialization partner for Ogluo in the UK, EEA, and Switzerland, Tetris Pharma, is to be acquired by Arecor Therapeutics PLC

Xeris Biopharma Holdings (NASDAQ:XERS) Inc has noted that Tetris Pharma - its commercialization partner for Ogluo in the UK, EEA, and Switzerland - is to be...

Related Keywords

United States ,United Kingdom ,Switzerland ,Gvoke Hypopen ,Tetris Pharma ,Paulr Edick ,Arecor Therapeutics ,European Medicines Agency ,European Commission ,Xeris Biopharma Holdings ,Committee For Medicinal Products Human Use ,Regulatory Agency ,United Kingdom Based ,European Economic Area ,Medicinal Products ,Human Use ,